Literature DB >> 8030743

Ultraviolet-induced p53 mutations in atypical fibroxanthoma.

A P Dei Tos1, R Maestro, C Doglioni, D Gasparotto, M Boiocchi, L Laurino, C D Fletcher.   

Abstract

Atypical fibroxanthoma (AFX) is an uncommon neoplasm of the superficial soft tissue occurring in actinically damaged skin of elderly patients. Sun-exposed skin also represents the main site of squamous and basal cell carcinomas and malignant melanoma, and a key role for ultraviolet (UV) radiation in their pathogenesis has long been suspected. UV-related mutations of the p53 gene have been identified in human skin cancers. To verify whether the pathogenesis of AFX is related to the effect of sunlight, p53 protein and gene status have been investigated in a series of 10 cases of AFX. Seven of 10 showed p53 immunoreactivity in most of the neoplastic cells. Molecular analysis of the p53 gene revealed an abnormal single strand conformation polymorphism pattern in all the p53 positive cases. Polymerase chain reaction direct sequencing revealed that all the mutations involved cytosine bases. Four cases showed C to T transitions (including two CC-TT double base substitutions) and two cases showed C to G transversion. All but one mutation took place at dipyrimidine sites. These findings provide the first objective evidence for the central role of UV radiation in the development of AFX and also represent the first in vivo demonstration of solar UV-induced mutations in a human mesenchymal neoplasm.

Entities:  

Mesh:

Year:  1994        PMID: 8030743      PMCID: PMC1887293     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  27 in total

1.  Carcinogens leave fingerprints.

Authors:  B Vogelstein; K W Kinzler
Journal:  Nature       Date:  1992-01-16       Impact factor: 49.962

2.  Latency, histology, and antigenicity of tumors induced by ultraviolet light in three inbred mouse strains.

Authors:  M L Kripke
Journal:  Cancer Res       Date:  1977-05       Impact factor: 12.701

3.  Influence of template strandedness on in vitro replication of mutagen-damaged DNA.

Authors:  K L Larson; B S Strauss
Journal:  Biochemistry       Date:  1987-05-05       Impact factor: 3.162

4.  The distribution of UV photoproducts along the human p53 gene and its relation to mutations in skin cancer.

Authors:  S Tornaletti; D Rozek; G P Pfeifer
Journal:  Oncogene       Date:  1993-08       Impact factor: 9.867

5.  Xeroderma pigmentosum. Cutaneous, ocular, and neurologic abnormalities in 830 published cases.

Authors:  K H Kraemer; M M Lee; J Scotto
Journal:  Arch Dermatol       Date:  1987-02

6.  A role for sunlight in skin cancer: UV-induced p53 mutations in squamous cell carcinoma.

Authors:  D E Brash; J A Rudolph; J A Simon; A Lin; G J McKenna; H P Baden; A J Halperin; J Pontén
Journal:  Proc Natl Acad Sci U S A       Date:  1991-11-15       Impact factor: 11.205

7.  Characterization of a dermal derived malignant mesenchymal tumor arising in ultraviolet irradiated mice.

Authors:  R G Phelps; L E Bernstein; N Harpaz; R E Gordon; F A Cruickshank; E Schwartz
Journal:  Am J Pathol       Date:  1989-07       Impact factor: 4.307

8.  The specificity of UV-induced mutations at an endogenous locus in mammalian cells.

Authors:  E A Drobetsky; A J Grosovsky; B W Glickman
Journal:  Proc Natl Acad Sci U S A       Date:  1987-12       Impact factor: 11.205

9.  The emerging epidemic of melanoma and squamous cell skin cancer.

Authors:  A G Glass; R N Hoover
Journal:  JAMA       Date:  1989-10-20       Impact factor: 56.272

10.  Activating mutations in p53 produce a common conformational effect. A monoclonal antibody specific for the mutant form.

Authors:  J V Gannon; R Greaves; R Iggo; D P Lane
Journal:  EMBO J       Date:  1990-05       Impact factor: 11.598

View more
  19 in total

1.  [Fibrohistiocytic tumors of the skin: a heterogeneous group of superficially located mesenchymal neoplasms].

Authors:  T Mentzel
Journal:  Pathologe       Date:  2015-02       Impact factor: 1.011

2.  Atypical Fibroxanthoma of the Conjunctiva in Xeroderma Pigmentosum.

Authors:  Nabeel Shalabi; Anat Galor; Sander R Dubovy; Jordan Thompson; J Antonio Bermudez-Magner; Carol L Karp
Journal:  Ocul Oncol Pathol       Date:  2015-04-15

3.  Atypical fibroxanthoma and pleomorphic dermal sarcoma harbor frequent NOTCH1/2 and FAT1 mutations and similar DNA copy number alteration profiles.

Authors:  Klaus G Griewank; Thomas Wiesner; Rajmohan Murali; Carina Pischler; Hansgeorg Müller; Christian Koelsche; Inga Möller; Cindy Franklin; Ioana Cosgarea; Antje Sucker; Dirk Schadendorf; Jörg Schaller; Susanne Horn; Thomas Brenn; Thomas Mentzel
Journal:  Mod Pathol       Date:  2017-11-03       Impact factor: 7.842

4.  Molecular aberrations of the G1-S checkpoint in myxoid and round cell liposarcoma.

Authors:  A P Dei Tos; S Piccinin; C Doglioni; T Vukosavljevic; T Mentzel; M Boiocchi; C D Fletcher
Journal:  Am J Pathol       Date:  1997-12       Impact factor: 4.307

5.  [Recurrent and metastasizing atypical fibroxanthoma].

Authors:  M Koch; A Dimmler; C Alexiou
Journal:  HNO       Date:  2008-10       Impact factor: 1.284

6.  Atypical fibroxanthoma in a young woman: An unusual case presentation.

Authors:  Mark M Melendez; Xiaoti Xu; Steve A McClain; Su-I Daniel Huang
Journal:  Can J Plast Surg       Date:  2007

7.  Atypical fibroxanthoma.

Authors:  Akio Sakamoto
Journal:  Clin Med Oncol       Date:  2008-02-09

8.  Overview of ultraviolet radiation and cancer: what is the link? How are we doing?

Authors:  M A Weinstock
Journal:  Environ Health Perspect       Date:  1995-11       Impact factor: 9.031

9.  Undifferentiated pleomorphic sarcoma in oropharyngeal mucosa of patients with multiple basal cell carcinomas.

Authors:  Andrea Dekanić; Marko Velepič; Margita Belušić Gobić; Ita Hadžisejdić; Nives Jonjić
Journal:  Rare Tumors       Date:  2021-06-30

10.  Mutation analysis of the Gadd45 gene at exon 4 in atypical fibroxanthoma.

Authors:  Akio Sakamoto; Shizuka Akieda; Yoshinao Oda; Yukihide Iwamoto; Masazumi Tsuneyoshi
Journal:  BMC Dermatol       Date:  2009-01-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.